Jamie L. Reynoso - 03 Jan 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO, Medicare Advantage
Signature: /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Issuer symbol: CLOV
Transactions as of: 03 Jan 2024
Net transactions value: -$24,141
Form type: 4
Filing time: 05 Jan 2024, 16:07:02 UTC
Previous filing: 03 Jan 2024
Next filing: 09 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	$24,141	-26,240	-1%	$0.9200	2,502,140	03 Jan 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2024, of twenty-five percent of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after January 3, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2024, of twenty-five percent of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after January 3, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date.